Emma Andrus, Associate Editor

The study uncovered sexual dimorphism in melanocyte stem cell migration rates due to UVB-induced inflammatory responses in mice.

Dermatology Times asked our readers to share what conferences they are looking forward to in the second quarter of 2024.

Keep up with the latest headlines in dermatology from the past week, including the discovery of a gene mutation that may cause psoriasis, the role of skin biopsies in detecting Parkinson's disease, and more.

ICYMI, this week we had news about bringing awareness to ethics in aesthetics, the 7 year anniversary of dupilumab's approval for atopic dermatitis, and more.

EltaMD representatives and dermatologists partook in the celebration on March 28 as a continuation of the celebration and momentum of the newly-established National Dermatologist Day.

Dermatology Times is looking back on the top stories in dermatology from the month of March.

Dermatology Times is recapping our top expert interviews from the month of March.

Researchers shared details of a noninvasive technique that detects abnormal inflammatory cytokine profiles in the skin of asymptomatic infant patients who subsequently develop AD.

Today officially marks 7 years since the US FDA approved dupilumab for the treatment of atopic dermatitis. Here's a look back at its approval timeline and all it has accomplished in the dermatology world in the time since.

Researchers from Google and Stanford Medicine recently partnered to develop the Skin Condition Image Network dataset, a tool aimed at providing image resources for conditions across skin tones.

Spizuoco shares pearls from her sessions, "Infectious Diseases: The Story Behind STDs," and "Everything You Need to Know About Dermatopathology and the Dermatopathologist," from the Diversity in Dermatology conference.

This framework considers both the pregnant patient who is taking the medication and the fetus who may be exposed to it while in the womb. It assesses potential benefits and risks for both parties.

We compare 2024 Match Day statistics with data from recent years.

Click here to answer today's poll and read more about recent uses of VR in dermatology education and practice.

Positive feelings accompanying BFRBs such as dermatillomania or trichotillomania may act as an important maintenance factor, researchers wrote.

Researchers analyzed the current treatment and research landscape for CLE in a review published in the Journal of Dermatology.

Keep up with the latest headlines in dermatology from the past week, including one dermatologist's journey with vascular birthmarks, award recipients, and more.

Papp shared insights from the recent STRIDE phase 2 trial, which met all its primary and secondary endpoints. Data was presented at the American Academy of Dermatology Annual Meeting.

Researchers developed a VR scenario skin cancer screening involving technical realization, curricular integration, and an evaluation of the subjective learning experience and teaching concept.

Late-breaking data demonstrating the sustained improvements was presented at the American Academy of Dermatology Annual Meeting.

Dermatology Times recently spoke with Latanya Benjamin, MD, FAAD, FAAP, the newly-appointed president of the WDS, to discuss her hopes and goals for her presidency.

The recommendations were recently published in JAMA Dermatology following an extensive literature review, article grading, and a review of research questions.

We take a look at various studies examining the role of artificial intelligence in telemedicine photo quality, the impact of the COVID-19 pandemic and skin cancer diagnoses, and more.

While additional, larger studies are necessary, researchers said dietary choices may help reduce dependency on pharmacological methods.

We spoke with several dermatology experts to gauge their thoughts on Valisure's recent findings of benzene in benzoyl peroxide products--as well as what actions they plan to take moving forward.

We take a look at various studies exploring the relationship between psoriasis and COVID-19 vaccination, the link between COVID-19 and psoriasis severity, and more.

Den, the chief medical officer of Alpha Tau, discusses the alpha particle-emitting atom treatment and its ability to target cancer cells without harming healthy tissue.

The expanded approval of Spevigo follows the Chinese National Medical Products Administration’s approval for the injection for the reduction of occurrence of GPP.

The FDA has assigned a Prescription Drug User Fee Act target action date for August 13.

It has been 4 years since the COVID-19 pandemic began. In the time since, there has been plentiful research regarding its implications in dermatology.